| LINE ITEM (USD / %) | FY 2025
FILED 2025-07-31 | FY 2024
FILED 2024-07-31 | FY 2023
FILED 2023-07-31 |
|---|---|---|---|
| Revenue (Total Sales) | $300.9M | $540.4M | $550.0M |
| YoY Revenue Growth % | -44.3% | -1.7% | — |
| Gross Profit | $95.2M | $157.2M | — |
| Gross Margin % | 31.6% | 29.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$29.9M | -$79.9M | -$14.7M |
| Operating Margin % | -9.9% | -14.8% | -2.7% |
| Net Income (GAAP) | -$155.3M | -$100.0M | -$26.9M |
| EBITDA (Normalized) | -$23.3M | -$69.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$8.3M | -$54.5M | -$4.4M |
| Capital Expenditures (CapEx) | $8.2M | $13.1M | — |
| Free Cash Flow (FCF) | -$16.5M | -$67.6M | -$4.4M |
| FCF Margin % | -5.5% | -12.5% | -0.8% |
| Return on Invested Capital (ROIC %) | -16.8% | -45.0% | — |
| Cash & Short-Term Equivalents | $32.8M | $26.7M | — |
| Total Debt (Short + Long Term) | $107.7M | $0 | — |
| Total Stockholders' Equity | $65.6M | $128.7M | — |